Dean Gray of the Technology Commercialization Group (TCG) will participate in The MedTech Conference, September 24 – 26, 2018, in Philadelphia. The MedTech Conference, sponsored by AdvaMed, brings together world-class plenary speakers, a wide array of commercialization, reimbursement, and regulatory programming, and valuable networking and business development opportunities for over 3,000 of the world’s leading medtech executives.
Meet with us for an introductory discussion on TCG’s strategic growth and business development solutions, and how we can assist you in launching a new product, planning entry into the US market, or finding a strategic partner.
Founded in 1998, TCG serves life science companies, including medical device, diagnostics, pharmaceutical, biotechnology, digital health and health IT companies from its offices in Research Triangle Park headquarters in North Carolina, USA, and Heidelberg, Germany. TCG assists its clients identify and assess new commercial opportunities, and develop and execute high-growth strategies. The firm also leads and advises transactions, including licensing, strategic partnerships, distribution agreements, asset sales, financings, and acquisitions. TCG provides interim management when an experienced executive is needed for a critical project, to enter a new market, or to refocus a company. TCG’s approach is different from other firms in that only senior TCG partners, with over 25 years of life science industry experience and a global network of industry contacts, lead assignments.